Posts tagged securities law.
Blogs
2 minute read
On March 22, 2011 the U.S. Supreme Court handed down a decision which is likely to have serious repercussions for companies in the bio/pharma tech space. In MATRIXX INITIATIVES, INC., ET AL. v. SIRACUSANO ET AL., the Court rejected Matrixx argument that reports regarding the adverse effect of Zicam, its leading revenue generating product, were not statistically significant and therefore not material.
Noting that the analysis of materiality under the securities laws in fact specific, the Court appears to have relied heavily on two factors:
1. The methodologies and requirements ...
Blog Editors
Recent Updates
- Attention Connecticut Warehouse Employers: Deadline for New Quota Notices Approaching
- New Jersey Department of Labor’s Guidance Clarifies Expanded Job Protected Leave Rights for Employees
- New York City Publishes Final Rules Related to the Earned Safe and Sick Time Act
- Watch: Beyond the EEOC - the Widening Divide in Disparate Impact Enforcement - Employment Law This Week
- The Death of Disparate Impact? What Recent DOJ Guidance Signals to Employers